TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News

Tech Stocks
3 Cheap Canadian Stocks That Can Deliver Superior Returns

Dividend Stocks
3 Types of Retirement Stocks to Buy in Your 30s

Cannabis Stocks
Cannabis Sector Paid $15 Billion in Taxes, But Still No Growth in Weed Stocks

Investing
Got $300? Buy These 3 Top Growth Stocks for Superior Returns

Cannabis Stocks
Tilray Stock: Risky Growth Stock or Value Pick?

Cannabis Stocks
Frustration, Not Profits: 3 Must-Avoid Weed Stocks in 2022

Investing
4 Cheap Canadian Stocks That You Can Buy Under $30

Investing
3 Growth Stocks That Could Outperform in 2022

Cannabis Stocks
TSX Today: What to Watch for in Stocks on Tuesday, January 11

Cannabis Stocks
Why Tilray Stock Soared on Monday

Investing
ON SALE: 3 Cheap TSX Stocks to Buy in January 2022
